supported by National Key R&D Program of China(Nos.2021YFA1302100,2021YFA1300200,2020YFE0202200);National Natural Science Foundation of China(Nos.82125034,82330115)。
For the first time,proteolysis-targeting chimeras(PROTAC)technology was utilized to achieve the isoform-selective degradation of class I phosphoinositide 3-kinases(PI3Ks)in this study.Through screening and optimizatio...
This work was supported by National Natural Science Foundation of China(No.82073044,and 81772503).
Phosphatidylinositol 3-kinases(PI3Ks)play key roles in tumorigenesis.PIK3CA,which encodes PI3K complex catalytic subunit p110a,is one of the most frequently mutated oncogenes in human cancers.1 So,targeting p110a hold...
This work was supported by the National Institutes of Health(R01DK118244);the American Heart Association(18IPA34140057);the American Diabetes Association(1-17-IBS-104);the faculty start up fund provided to S.W.P.from Boston Children’s Hospital.
Bromodomain-containing protein 7 (BRD7) has been shown to interact with the regulatory subunit of phosphatidylinositol 3-kinase(PI3K), p85, in the insulin signaling pathway. Here, we show that upregulation of hepatic ...